Fentanyl-blocking effects of extended-release naltrexone in humans: Three case reports.  Brewer C.  J Opioid Manag. 2025 Jul-Aug;21(4):355-359. doi: 10.5055/jom.0949. PMID: 40910985. Abstract https://wmpllc.org/ojs/index.php/jom/articl…

Reversal of a synthetic opioid overdose: Insights from a validated translational model.  Laffont CM, Purohit P, de la Peña A, Skolnick P.  Neuropharmacology. 2025 Nov 1;278:110546. doi: 10.1016/j.neuropharm.2025.110546. Epub 2025 Jun 6…

Shifting Cohort Patterns in the Use of Drugs with Elevated Overdose Risk in the United States.  England K, Luo L, Verdery AM, Monnat SM.  Soc Probl. 2025 Aug;72(3):1239-1259. doi: 10.1093/socpro/spae013. Epub 2024 Mar 25. PMID: 40785729;…

Understanding the Opioid Epidemic as an Environmental Injustice Ezell, Jerel M. American Journal of Preventive Medicine, Volume 69, Issue 5, 108047 https://www.ajpmonline.org/article/S0749-3797(25)00522-7/fulltexthttps://www.ajpmonline.org/articl…

München. Prävention von Drogentod - Hybrid-Fachtagung am 14.10.2025  In Deutschland erreichte die Zahl der drogenbedingten Todesfälle im Jahr 2023 ein Rekordniveau und liegt fast doppelt so hoch wie vor zehn Jahren. Vor diesem Hintergrund widm…

10 times stronger than fentanyl, nitazenes are the latest, deadly development in the synthetic opioid crisis  At the end of 2023, the health crisis caused by fentanyl use in the United States set alarm bells ringing. However, the situatio…